Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Asset Writedowns and Impairment (2020 - 2025)

Zai Lab's Asset Writedowns and Impairment history spans 6 years, with the latest figure at -$1000.0 for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment fell 101.72% year-over-year to -$1000.0; the TTM value through Sep 2025 reached -$814000.0, down 1200.0%, while the annual FY2023 figure was $6000.0, 98.74% down from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was -$1000.0 at Zai Lab, up from -$26000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $755000.0 in Q2 2024 and bottomed at -$814000.0 in Q4 2024.
  • The 5-year median for Asset Writedowns and Impairment is $1000.0 (2021), against an average of $25947.4.
  • The largest annual shift saw Asset Writedowns and Impairment skyrocketed 48200.0% in 2022 before it crashed 24566.67% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $5000.0 in 2021, then plummeted by 160.0% to -$3000.0 in 2022, then plummeted by 24566.67% to -$740000.0 in 2023, then dropped by 10.0% to -$814000.0 in 2024, then surged by 99.88% to -$1000.0 in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Asset Writedowns and Impairment are -$1000.0 (Q3 2025), -$26000.0 (Q2 2025), and $27000.0 (Q1 2025).